U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07676565) titled 'Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study' on June 24.
Brief Summary: This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.
Study Start Date: March 24
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes
Recruitment Status: RECRUITING
Sponsor: Indiana University
Information provided by (Responsible Party): Viral N. Shah, Indiana University
Dis...